Member Info for Valhalla14

It helps in the fact it gets you back to the workplace....back into society knowing that you have antibodies in your system tells you that your immune system has done its job and gives peace of mind

The trolls out last night then

Talk about an embarrassment.....scruffy....can't be bothered to shave.....CEO of Tally

https://www.youtube.com/watch?v=UqMuBl-JWsM&feature=youtu.be&fbclid=IwAR3JkTOl5v5dIzq4WJXRXNMCNVoVApye9WgyTtoTMm5XheKjVF75c1ZxTcg

Leaving the building....will be back up later today

The only thing that's happening is CP is being paid....that's all that matters to him....

Oh well done.....clown

Ok princess.....you hold your boyfriends hand as he needs your support

barwickman go play with the traffic......certainly got more invested here than you have and for longer you fool

why do you flood the board with utter rubbish wadnob?

RNS Number : 3536U
FastForward Innovations Limited
28 July 2020


FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

28 July 2020

FastForward Innovations Ltd ("FastForward" or, "FFWD")



Investee Company Update: EMMAC Life Sciences



FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note the following announcement released today concerning investee company EMMAC Life Sciences ('EMMAC'). FastForward has a 2.3% interest in the issued stock of EMMAC.



Ed McDermott, CEO of FastForward, commented: "It is extremely pleasing to see Medalchemy achieving yet another significant license which further enhances EMMACs position in Europe. I look forward to providing further updates as EMMAC continues to strengthen its position as the leading European independent cannabis company."



The announcement is set out below without material changes or adjustments.



Medalchemy receives licence for cultivation of medical cannabis. Spanish EU GMP Facility now has licences to cultivate, extract and manufacture cannabis extract



28 July 2020, London. EMMAC Life Sciences Group, Europe's largest independent cannabis company, is pleased to announce that Medalchemy, the Group's Good Manufacturing Practice ("GMP") certified manufacturing site in Alicante, Spain has secured approval from the Spanish Health Authorities ("AEMPS") to cultivate medical cannabis. Medalchemy now has fully integrated cannabis supply facilities, with a licence to grow medical cannabis commercially as well as extract and manufacture cannabis extract as an active pharmaceutical ingredient ("API").



EMMAC holds two medical cannabis cultivation licences, one in Spain, at Medalchemy, and the second in Portugal, at its primary cultivation site Terra Verde, which in 2020 has produced and exported c.2 tonnes of medical cannabis flower. EMMAC now holds multiple medical cannabis licences in 4 countries across Europe.



Antonio Costanzo, CEO of EMMAC, said: "This latest licence to cultivate medical cannabis at our EU-GMP Facility in Alicante strengthens EMMAC's position as the leading European independent cannabis company with two cultivation facilities and an alternative point of supply for our business. With full control of our supply chain we are able to ensure a consistent, reliable and high-quality product that our growing customer base can trust. As European legislation quickly evolves to reflect the growing body of medical evidence regarding the benefits of medical cannabis, EMMAC's integrated business model positions it well to capitalise on the high-growth potential of this valuable market."



Last week, EMMAC announced that the Company signed a non-bindling letter of intent related to a business combination with Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) ("Andina"), pursuant to which EMMAC would beco

Indivior Announces Agreement to Resolve Criminal Charges and Civil Complaints Related to SUBOXONE® Film



Slough, UK and Richmond, VA, July 24, 2020 - Indivior PLC (LON: INDV) ("Indivior" or the "Company") announced that it has reached an agreement with the United States Department of Justice (Justice Department), the Federal Trade Commission ("FTC"), and U.S. state attorneys general to resolve the Company's criminal and civil liability in connection with an indictment brought in April 2019 by a grand jury in the Western District of Virginia, a civil lawsuit joined by the Justice Department in 2018, and an FTC investigation. Under the terms of the agreement, Indivior Solutions Inc ("Solutions Inc"), a wholly-owned subsidiary of Indivior PLC, has pleaded guilty to one count of making a false statement relating to health care matters in 2012. Indivior will make payments to federal and state authorities totaling $600 million over a period of seven years, has agreed to a stipulated injunction with the FTC, and entered into a Corporate Integrity Agreement with the Office of Inspector General of the Department of Health and Human Services ("HHS"). Under the terms of the agreement, the Justice Department will move to dismiss all charges returned by a grand jury in April 2019.



Under the terms of a related agreement with the HHS, Solutions Inc will be excluded from participating in government health programs. This exclusion will not affect Indivior PLC or its other subsidiaries (together the "Group"). Indivior does not anticipate the exclusion of Solutions Inc will have any material impact on the Group's ability to continue to participate in government health programs.



"We are pleased to achieve this resolution and move forward in a way that provides certainty for our business in respect of this matter and allows us to continue focusing on our important work for patients suffering from opioid use disorder and mental health illnesses around the world," said Indivior Chief Executive Officer Mark Crossley. "The incident to which the agreement relates occurred well in the past and does not reflect the values Indivior has strived to demonstrate and uphold during our long history of partnering with healthcare providers, policymakers, and communities to fight the opioid crisis."



Under the terms of the agreement, the Group will distribute a payment of $100 million the week the plea is finalized and approved by a judge. Subsequently, there will be six annual installments of $50 million due every January 15 from 2022 to 2027. The final balance will be due on December 15, 2027. The Group carries a provision of $624 million for Department of Justice and related matters.



Under the terms of the five-year Corporate Integrity Agreement with the HHS Office of the Inspector General, the Group will continue its commitment to promoting compliance with laws and regulations and its ongoing evolution of an effective compliance program, incl

That's correct unvrkw because there's an auction to finish the day with and balance the book....what amazes me is you don't have a clue about the auction process and UT closing trade....if you don't know then ask or do some studying to understand it better....here's a link for you and it's got nothing to do with being behind a screen chap.

https://aim-watch.com/project/lse-auctions-explained/

What are you talking about unvrkw the share price closed at 57p which is the UT (uncrossing trade) after auction 16:35:10 57.00 7,556 4,307 UT..... " the SP moves loads after 4:30 " this board is plagued with absolute clowns

Closed at 57p Desciple13 16:35:10 57.00 7,556 4,307 UT

Running on *rap trying to predict the SP....hilarious...Hardcore1 filtered

EnricoPallazzo what an absolute clown you are.....target? CLOWN

Classic MM ploy to relieve the weak of their shares

right guys and gals ....I am being targeted by certain usernames that have been told to instigate trouble....or try to press buttons....I am now thinking of issuing a writ to Tally and play with a few old school laws....no ceo or staff of tally are playing with me....they read all this bb so let it be known....wrong move to target shareholders

08:37:27 45.00 300,000 135.00k O

08:35:57 44.9167 300,000 134.75k O

OMEGA DIA
ODX
48.50 +7.80 (+19.16%)